首頁 > 市場調查報告書 > 製藥

癌症生物標記

市場調查報告書

商品編碼

1672664

癌症生物標記市場：按生物標記類型、按癌症類型、按分析技術、按最終用途、按地區

Cancer Biomarkers Market, By Biomarker Type, By Cancer Type, By Profiling Technology, By End User, By Geography

出版日期: 2025年02月12日 | 出版商:

Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球癌症生物標記市場規模估計為 289 億美元，預計到 2032 年將達到 676.2 億美元，2025 年至 2032 年的複合年成長率為 12.9%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	289億美元
效能資料	從 2020 年到 2024 年	預測期	2025 至 2032 年
預測期：2025-2032年複合年成長率：	12.90％	2032 年價值預測	676.2億美元

數字。 2025 年各地區癌症生物標記市場佔有率（%）

癌症生物標記是血液、組織或其他體液中發現的生物分子，可指示正常或異常過程、狀況或疾病。這些可用於檢測和監測癌症和癌症進展。近年來，癌症生物標記引起了世界各地公共和私人組織的極大關注，因為它們為癌症的診斷、分期和追蹤提供了微創方法。這些生物標記也使腫瘤學家能夠根據每個患者的癌症狀況制定個人化治療方案。基因分析和高通量技術的進步釋放了生物標記的潛力，可以更準確地預測治療反應和疾病進展。這對於改善全球癌症治療具有良好的意義。

市場動態：

全球癌症生物標記市場的成長得益於全球癌症發病率的上升、精準醫療和伴同性診斷的日益普及以及生物標記在藥物開發和核准中的應用日益增多。然而，發現、檢驗和商業化生物標記的高成本仍然是一個挑戰。此外，技術限制和缺乏報銷也抑制了市場的成長。市場正在從癌症人口眾多且醫療支出不斷上升的新興國家中看到豐厚的商機。此外，透過正在進行的研究活動發現新的生物標記物，特別是針對難以治療的癌症的生物標記物，可能會創造更多的商機。

本研究的主要特點

本報告對全球癌症生物標記市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模和年複合成長率（CAGR%），假設 2024 年為基準年。
它還揭示了不同領域的潛在商機並解釋了該市場的引人注目的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，介紹了全球癌症生物標記市場的主要企業概況。
本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球癌症生物標記市場報告涵蓋該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
透過用於分析全球癌症生物標記市場的各種策略矩陣，投資者將發現他們的決策更加容易。

bioMerieux, Inc.
INOVIQ
Bio-Rad Laboratories, Inc.
Abbott
Becton, Dickinson and Company
Merck KGaA
QIAGEN
Thermo Fisher Scientific Inc.
CENTOGENE NV
PerkinElmer Inc.
Siemens Healthineers
F. Hoffmann-la Roche Ltd
Agilent Technologies, Inc
Invitae Corporation
Myriad Genetics
Guardant Health
Illumina
FOUNDATION MEDICINE, INC.

第 11 章分析師觀點

命運之輪
分析師觀點
一致的機會地圖

第 12 章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI175

Global Cancer Biomarkers Market is estimated to be valued at USD 28.90 Bn in 2025 and is expected to reach USD 67.62 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.9% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 28.90 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	12.90%	2032 Value Projection:	USD 67.62 Bn

Figure. Cancer Biomarkers Market Share (%), By Region 2025

Cancer biomarkers are biological molecules found in blood, tissues or other body fluids that are sign of a normal or abnormal process, or of a condition or disease. These can be used to detect and monitor cancer or cancer progression. In recent years, cancer biomarkers have gained significant attention from both global public and private organizations as these present minimally invasive ways to diagnose, stage and track cancer. Their use also enables oncologists to personalize treatments based on individual patient's cancer profiles. Advancements in genetic profiling and high-throughput technologies have unlocked the potential of biomarkers that can predict treatment responses and disease progression more accurately. This has promising implications for improving cancer care globally.

Market Dynamics:

Global cancer biomarkers market growth is driven by rising cancer prevalence worldwide, increasing popularity of precision medicine and companion diagnostics, and growing use of biomarkers in drug development as well as approvals. However, high costs associated with biomarker discovery, validation, and commercialization pose a challenge. Moreover, technical limitations and lack of reimbursements restrain the market growth. The market witnesses lucrative opportunities from emerging economies with large cancer populations and growing health expenditures. Further opportunities lie in discovery of novel biomarkers especially for hard-to-treat cancers through ongoing research efforts.

Key Features of the Study:

This report provides in-depth analysis of the global cancer biomarkers market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cancer biomarkers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study includes bioMerieux Inc., INOVIQ, Bio-Rad Laboratories Inc., Abbott, Becton Dickinson and Company, Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific Inc., CENTOGENE N.V., PerkinElmer Inc., Siemens Healthineers, F. Hoffmann-la Roche Ltd, Agilent Technologies, Inc, Invitae Corporation, Myriad Genetics, Guardant Health, Illumina, and FOUNDATION MEDICINE, INC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global cancer biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer biomarkers market

Detailed Segmentation-

Biomarker Type:
- CA 125
- HER2
- EGFR
- CD20
- BRAF
- Calcitonin
- Others
Cancer Type
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Kidney Cancer
- Liver Cancer
- Head & neck Cancer
- Non-small Cell Lung Cancer
- Other Cancers
Profiling Technology:
- OMICS Technology
- Imaging Technology
- Immunoassays
- Cytogenetics
- Others
End User:
- Hospitals
- Specialty Clinics
- Diagnostic Laboratories
- Academic Research Institutes
- Others
Regional:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- bioMerieux Inc.
- INOVIQ
- Bio-Rad Laboratories Inc.
- Abbott
- Becton Dickinson and Company
- Merck KgaA
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
- CENTOGENE N.V.
- PerkinElmer Inc.
- Siemens Healthineers
- Hoffmann-la Roche Ltd
- Agilent Technologies, Inc
- Invitae Corporation
- Myriad Genetics
- Guardant Health
- Illumina
- FOUNDATION MEDICINE, INC.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Biomarker Type
- Market Snapshot, By Cancer Type
- Market Snapshot, By Profiling Technology
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
PEST Analysis

4. Global Cancer Biomarkers Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Impact on Supply and Demand
COVID-19 Impact on the market

5. Global Cancer Biomarkers Market, By Biomarker Type, 2020 - 2032, (USD BN)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
CA 125
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
HER2
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
EGFR
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
CD20
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
BRAF
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Calcitonin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

6. Global Cancer Biomarkers Market, By Cancer Type, 2020 - 2032, (USD BN)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Breast Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Lung Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Prostate Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Kidney Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Liver Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Head & neck Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Non-small Cell Lung Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Other Cancers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

7. Global Cancer Biomarkers Market, By End User, 2020 - 2032, (USD BN)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
OMICS Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Imaging Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Immunoassays
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Cytogenetics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

8. Global Cancer Biomarkers Market, By End User, 2020 - 2032, (USD BN)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Diagnostic Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

9. Global Cancer Biomarkers Market, By Region, 2020 - 2032, (USD BN)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
Africa

10. Competitive Landscape

bioMerieux, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
INOVIQ
Bio-Rad Laboratories, Inc.
Abbott
Becton, Dickinson and Company
Merck KGaA
QIAGEN
Thermo Fisher Scientific Inc.
CENTOGENE N.V.
PerkinElmer Inc.
Siemens Healthineers
F. Hoffmann-la Roche Ltd
Agilent Technologies, Inc
Invitae Corporation
Myriad Genetics
Guardant Health
Illumina
FOUNDATION MEDICINE, INC.